RE:RE:RE:RE:RE:Share priceLets play the blame game: whos at fault? Lets see. Shareholders: were investors who have confidence in the product, so cant be us. Shorters: they are investors, just like us, but they have no confidence in the product, so cant be them. Hospitals: they are clients of TSO3 and clients are always right, so cant be at fault if they havent heard of the product. Doctors: they are the end users but not the buyers and would surely prefer using the VP4 if they were available: they can't be at fault. Hospital patients: theyd rather undergo procedures using sterilized medical equipment, but they have no idea what is a VP4, so they cant put pressure on their doctors; cant be them; FDA: well, they approved the (original de novo) VP4 many, many moons ago and it didnt sell, so they cant be blamed. OK, they granted the last authorization not too long ago, but they cant be blamed to make sure the VP4s meet with all necessary criteria to safeguard patients health and medical equipment integrity. 3M: smart company knew better and decided to cut their losses, so cant fault their management; Getinge: company whose management was in turmoil that bought numerous VP4s (read: got TSO3 out of a whole through an interesting financial arrangement to help TSO3 get rid of inventory) who also decided to cut their losses by taking a bath on selling the same VP4s back to TSO3. TSO3 never officially or directly put the burden on Getinge for not selling the stuff. Hell, TSO3 decided to entrust their competitor with the sales process. So, can we really put the blame on Getinge? Lawyers: for not suing hospitals and doctors for malpractice considering unsterilized medical instruments harming patients? Probably Just kidding. How about us, gullible investors who believed the stories we were told over the years? Smart shareholder would have jumped ship a long time ago and some did, ask Mr. Rumble. I could go on and on finding culprits, but I believe TSO3s management must share some of the blame, dont you think? Over many years, we were not told the truth: go on, read past management reports, bulletins or corporate documents and you will see what Im talking about: a tissue of untruths and deceptions. Oups, I was forgetting about Mr. Rumble: he exercised options way ahead of their expiration dates, pocketing $1,787,560. on 10 August 2016 at $ 4.00 and $1,500 000. on 23 May 2017 at $3.50. This last transaction took place immediately, I repeat, immediately before the share price plummeted. Shrewd investor, isnt he? I cant blame him since he was smart enough to cut his losses I wonder who his financial advisor is that predicted the ultimate share price plunge? Oh, but wait: unlike us gullible investors, Mr. Rumble did not invest much, if any, of his hard-earned money in this failing venture, only his time for which he was handsomely rewarded in salary, hundreds of thousands of options and, of all things, PERFORMANCE BONUSES. I sincerely believe that us, frustrated shareholders, have an absolute right to criticize the past performance of TSO3s management but I also wish that our recriminations will ultimately prove to be unwarranted. However, time is running out before TSO3s directors and officers are pressed to account for their lackluster management of the company.